Abstract
Clinical experience with using an aromatase inhibitor to suppress estrogen production during puberty for improvement of growth potential in adolescents with short stature is limited. This report documents treatment of such a patient with a combination of growth hormone and letrozole, a third-generation aromatase inhibitor. Our case demonstrates a favorable outcome on a short-term basis.
Original language | English (US) |
---|---|
Pages (from-to) | e245-e248 |
Journal | Pediatrics |
Volume | 115 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2005 |
Externally published | Yes |
Keywords
- Aromatase inhibitor
- Bone mineral density
- Growth hormone
- Hormonal control
- Short stature
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health